195 related articles for article (PubMed ID: 28234969)
1. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
Kimaro GD; Mfinanga S; Simms V; Kivuyo S; Bottomley C; Hawkins N; Harrison TS; Jaffar S; Guinness L;
PLoS One; 2017; 12(2):e0171917. PubMed ID: 28234969
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
Mfinanga S; Chanda D; Kivuyo SL; Guinness L; Bottomley C; Simms V; Chijoka C; Masasi A; Kimaro G; Ngowi B; Kahwa A; Mwaba P; Harrison TS; Egwaga S; Jaffar S;
Lancet; 2015 May; 385(9983):2173-82. PubMed ID: 25765698
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcal Meningitis Screening and Community-based Early Adherence Support in People With Advanced Human Immunodeficiency Virus Infection Starting Antiretroviral Therapy in Tanzania and Zambia: A Cost-effectiveness Analysis.
Kimaro GD; Guinness L; Shiri T; Kivuyo S; Chanda D; Bottomley C; Chen T; Kahwa A; Hawkins N; Mwaba P; Mfinanga SG; Harrison TS; Jaffar S; Niessen LW
Clin Infect Dis; 2020 Apr; 70(8):1652-1657. PubMed ID: 31149704
[TBL] [Abstract][Full Text] [Related]
4. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
[TBL] [Abstract][Full Text] [Related]
5. Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania.
Geldsetzer P; Francis JM; Sando D; Asmus G; Lema IA; Mboggo E; Koda H; Lwezaula S; Ambikapathi R; Fawzi W; Ulenga N; Bärnighausen T
PLoS Med; 2018 Sep; 15(9):e1002659. PubMed ID: 30231024
[TBL] [Abstract][Full Text] [Related]
6. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
[TBL] [Abstract][Full Text] [Related]
8. Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia.
Marseille E; Giganti MJ; Mwango A; Chisembele-Taylor A; Mulenga L; Over M; Kahn JG; Stringer JS
PLoS One; 2012; 7(12):e51993. PubMed ID: 23284843
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
Medina Lara A; Kigozi J; Amurwon J; Muchabaiwa L; Nyanzi Wakaholi B; Mujica Mota RE; Walker AS; Kasirye R; Ssali F; Reid A; Grosskurth H; Babiker AG; Kityo C; Katabira E; Munderi P; Mugyenyi P; Hakim J; Darbyshire J; Gibb DM; Gilks CF;
PLoS One; 2012; 7(4):e33672. PubMed ID: 22545079
[TBL] [Abstract][Full Text] [Related]
10. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
Koenig SP; Bang H; Severe P; Jean Juste MA; Ambroise A; Edwards A; Hippolyte J; Fitzgerald DW; McGreevy J; Riviere C; Marcelin S; Secours R; Johnson WD; Pape JW; Schackman BR
PLoS Med; 2011 Sep; 8(9):e1001095. PubMed ID: 21949643
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa.
Walker SM; Cox E; Revill P; Musiime V; Bwakura-Dangarembizi M; Mallewa J; Cheruiyot P; Maitland K; Ford N; Gibb DM; Walker AS; Soares M;
J Int AIDS Soc; 2020 Mar; 23(3):e25469. PubMed ID: 32219991
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
[TBL] [Abstract][Full Text] [Related]
14. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis.
Scott CA; Iyer H; Bwalya DL; McCoy K; Meyer-Rath G; Moyo C; Bolton-Moore C; Larson B; Rosen S
PLoS One; 2013; 8(6):e67910. PubMed ID: 23840788
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.
Smith JA; Sharma M; Levin C; Baeten JM; van Rooyen H; Celum C; Hallett TB; Barnabas RV
Lancet HIV; 2015 Apr; 2(4):e159-68. PubMed ID: 25844394
[TBL] [Abstract][Full Text] [Related]
16. The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania.
Geldsetzer P; Francis JM; Ulenga N; Sando D; Lema IA; Mboggo E; Vaikath M; Koda H; Lwezaula S; Hu J; Noor RA; Olofin I; Larson E; Fawzi W; Bärnighausen T
BMC Health Serv Res; 2017 Feb; 17(1):160. PubMed ID: 28228134
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for improving the efficiency of paediatric HIV treatment programmes.
Revill PA; Walker S; Mabugu T; Nathoo KJ; Mugyenyi P; Kekitinwa A; Munderi P; Bwakura-Dangarembizi M; Musiime V; Bakeera-Kitaka S; Nahirya-Ntege P; Walker AS; Sculpher MJ; Gibb DM
AIDS; 2015 Jan; 29(2):201-10. PubMed ID: 25396263
[TBL] [Abstract][Full Text] [Related]
18. Health care costs associated with clinic visits for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania.
Naburi HE; Mujinja P; Kilewo C; Biberfeld G; Bärnighausen T; Manji K; Lyatuu G; Urrio R; Zethraeus N; Orsini N; Ekström AM
Medicine (Baltimore); 2021 Nov; 100(46):e27828. PubMed ID: 34797311
[TBL] [Abstract][Full Text] [Related]
19. Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe.
Chingombe I; Mapingure MP; Balachandra S; Chipango TN; Gambanga F; Mushavi A; Apollo T; Suraratdecha C; Rogers JH; Ruangtragool L; Gonese E; Musuka GN; Mugurungi OM; Harris TG
PLoS One; 2021; 16(8):e0256291. PubMed ID: 34407129
[TBL] [Abstract][Full Text] [Related]
20. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
Mfinanga SG; Kirenga BJ; Chanda DM; Mutayoba B; Mthiyane T; Yimer G; Ezechi O; Connolly C; Kapotwe V; Muwonge C; Massaga J; Sinkala E; Kohi W; Lyantumba L; Nyakoojo G; Luwaga H; Doulla B; Mzyece J; Kapata N; Vahedi M; Mwaba P; Egwaga S; Adatu F; Pym A; Joloba M; Rustomjee R; Zumla A; Onyebujoh P
Lancet Infect Dis; 2014 Jul; 14(7):563-71. PubMed ID: 24810491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
